Loading
Life sciences · Journal article
American Journal of Medical and Biological Research · September 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Fungal infections constitute an increasingly important global public health problem and are associated with substantial morbidity and mortality, particularly among immunocompromised and critically ill individuals. They range from highly prevalent superficial mycoses to invasive and disseminated infections with high case-fatality rates. Opportunistic pathogens, such as Aspergillus, Candida, Cryptococcus, Rhodotorula, Geotrichum, and Trichosporon cause diverse clinical syndromes, whereas endemic dimorphic fungi including Blastomyces, Coccidioides, Histoplasma, Paracoccidioides, and Talaromyces are strongly influenced by environmental and geographic exposure. Recent global estimates suggest that more than 6.5 million life-threatening invasive fungal infections occur annually, with approximately 3.8 million associated deaths. Climate change may alter fungal ecology, geographic distribution, and human exposure, while antifungal resistance increasingly compromises the effectiveness of the limited therapeutic options available. This review summarizes the epidemiology, major opportunistic and endemic mycoses, global morbidity and mortality, climate-related emergence, and antifungal resistance, and highlights the need for improved surveillance, laboratory diagnosis, antifungal stewardship, access to effective treatment, and coordinated One Health interventions.